Sandra Dunn

Biography

  Between 2001 and 2015, Dr. Sandra Dunn led a highly successful cancer research program in the Faculty of Medicine, Experimental Medicine Program at the University of British Columbia. During her time at UBC, she mentored over 70 students and developed five provisional patents relating to the development of new therapies aimed at reducing drug resistance in cancer treatment. Two of the patents were registered internationally. Sandra obtained her BA from Hiram College, a leading private school in the United States. She then spent five years in industry and government as an analytical chemist before pursing an MSc and Ph.D. in applied toxicology and biotechnology at North Carolina State University. After obtaining her Ph.D., Sandra trained as a postdoctoral fellow for five years at the National Institutes of Health in the Research Triangle Park in North Carolina. The focus of her research over the past 20 years has been the identification of novel methods of diagnosing and treating cancers that primarily affect women and children. Throughout her career Sandra has published more than 80 peer-reviewed manuscripts, the majority of which discuss the identification and validation of novel strategies for the treatment of cancer. She is an internationally recognized and respected cancer researcher.

Research Interest

Pharmaceutical Analysis and Quality Assurance  Industrial Pharmacy Clinical Pharmacy  Pharmaceutical Administration Medicinal Chemistry  Drug Discovery and Development